Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 1064 of 3330
Next
>>
>
26576 to 26600 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MCF 10F	NM	-	FR180204	ERK1/2	MAPK	20	uM	12254.161	1.1911	1.2663	1.3991
MCF 10F	NM	-	FR180204	ERK1/2	MAPK	100	uM	12254.161	0.1994	-0.3684	1.3991
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	0.0000853	uM	10817.149	0.9677	0.9557	1.4656
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	0.000427	uM	10817.149	0.9919	0.9889	1.4656
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	0.00213	uM	10817.149	1.0030	1.0041	1.4656
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	0.0107	uM	10817.149	0.9856	0.9803	1.4656
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	0.0533	uM	10817.149	0.9607	0.9460	1.4656
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	0.267	uM	10817.149	0.9791	0.9714	1.4656
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	1.33	uM	10817.149	1.0157	1.0214	1.4656
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	6.67	uM	10817.149	0.9708	0.9600	1.4656
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	33.3	uM	10817.149	0.7835	0.6932	1.4656
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	0.000256	uM	12365.166	1.0046	1.0048	1.8961
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	0.00128	uM	12365.166	0.9906	0.9901	1.8961
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	0.0064	uM	12365.166	1.0316	1.0331	1.8961
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	0.032	uM	12365.166	1.0287	1.0301	1.8961
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	0.16	uM	12365.166	0.9906	0.9900	1.8961
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	0.8	uM	12365.166	1.0485	1.0506	1.8961
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	4	uM	12365.166	1.0455	1.0475	1.8961
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	20	uM	12365.166	1.1393	1.1424	1.8961
MCF12A	NM	Basal B	FR180204	ERK1/2	MAPK	100	uM	12365.166	0.7453	0.7128	1.8961
MCF7	HR+	Luminal	FR180204	ERK1/2	MAPK	0.0000853	uM	10997.149	1.0333	1.0527	1.2614
MCF7	HR+	Luminal	FR180204	ERK1/2	MAPK	0.000427	uM	10997.149	1.0211	1.0334	1.2614
MCF7	HR+	Luminal	FR180204	ERK1/2	MAPK	0.00213	uM	10997.149	1.0216	1.0342	1.2614
MCF7	HR+	Luminal	FR180204	ERK1/2	MAPK	0.0107	uM	10997.149	0.9966	0.9946	1.2614
MCF7	HR+	Luminal	FR180204	ERK1/2	MAPK	0.0533	uM	10997.149	1.0130	1.0205	1.2614

|<
<<
Previous
Page 1064 of 3330
Next
>>
>
26576 to 26600 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)